Markets & Stocks
Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, & More From Curity Pharma
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
